Patents by Inventor Oskar Kalb

Oskar Kalb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release oral formulations
    Publication number: 20070053982
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
    Type: Application
    Filed: November 3, 2006
    Publication date: March 8, 2007
    Inventors: Jorg Ogorka, Oskar Kalb, Rajen Shah, Satish Khanna
  • Oral controlled release formulations
    Publication number: 20060246101
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigmine, in a time-controlled manner.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 2, 2006
    Inventors: Rajen Shah, Satish Khanna, Oskar Kalb, Jorg Ogorka
  • Pharmaceutical compositions comprising fluvastatin
    Publication number: 20060127474
    Abstract: Pharmaceutical compositions comprising fluvastatin, HPMC and optionally other pharmaceutical excipients which are colour-stable upon prolonged periods of storage.
    Type: Application
    Filed: February 3, 2006
    Publication date: June 15, 2006
    Inventors: Oskar Kalb, Stephen Valazza
  • High drug load tablet
    Publication number: 20050267125
    Abstract: The present invention pertains to a high drug load tablet comprising as active ingredient Compound I of formula or a pharmaceutically acceptable salt thereof in an amount from about 30% to 80% in weight of the active moiety based on the total weight of the tablet.
    Type: Application
    Filed: April 22, 2003
    Publication date: December 1, 2005
    Inventors: Christian-Peter Luftensteiner, Jean-Claude Bianchi, Jorg Ogorka, Oskar Kalb
  • Sustained release oral formulations
    Publication number: 20050175706
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigmine, in a time-controlled manner.
    Type: Application
    Filed: April 14, 2005
    Publication date: August 11, 2005
    Inventors: Jorg Ogorka, Oskar Kalb, Rajen Shah, Satish Khanna
  • Pharmaceutical compositions containig terbinafin and use thereof
    Publication number: 20040198838
    Abstract: Pharmaceutical compositions for oral administration comprising terbinafine and a method for administering high dosages while minimizing effects associated with e.g. a high dosage load, e.g. coated tablets or multiparticulate formulations such as minitablets or pellets, e.g. in capsules.
    Type: Application
    Filed: May 21, 2004
    Publication date: October 7, 2004
    Inventors: Rainer Alles, Dieter Becker, Jean-Daniel Bonny, Stefan Hirsch, Oskar Kalb, Ernst Ulrich Kolle, Friedrich Karl Mayer, Anton Stutz, Anthony Williams
  • Sustained release oral formulations
    Publication number: 20030203025
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
    Type: Application
    Filed: March 31, 2003
    Publication date: October 30, 2003
    Inventors: Jorg Ogorka, Oskar Kalb, Rajen Shah, Satish Chandra Khanna
  • Pharmaceutical compositions comprising fluvastatin
    Publication number: 20030171419
    Abstract: Pharmaceutical compositions comprising fluvastatin, HPMC and optionally other pharmaceutical excipients which are colour-stable upon prolonged periods of storage.
    Type: Application
    Filed: October 15, 2002
    Publication date: September 11, 2003
    Inventors: Oskar Kalb, Stephen Valazza
  • Controlled release oral compositions comprising rivastigmine
    Patent number: 6565883
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: May 20, 2003
    Assignee: Novartis AG
    Inventors: Jörg Ogorka, Oskar Kalb, Rajen Shah, Satish Chandra Khanna
  • Sustained release oral formulations
    Publication number: 20030039692
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
    Type: Application
    Filed: April 8, 2002
    Publication date: February 27, 2003
    Inventors: Jorg Ogorka, Oskar Kalb, Rajen Shah, Satish C. Khanna
  • Sustained release oral formulations
    Publication number: 20010033866
    Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
    Type: Application
    Filed: March 27, 2001
    Publication date: October 25, 2001
    Inventors: Jorg Ogorka, Oskar Kalb, Rajen Shah, Satish Chandra Khanna
  • Combine capsule and tablets
    Patent number: D520635
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: May 9, 2006
    Assignee: Novartis AG
    Inventors: Jean-Daniel Bonny, Stefan Hirsch, Oskar Kalb, Peter Pietzonka
  • Combined capsule and tablets
    Patent number: D530814
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: October 24, 2006
    Assignee: Novartis AG
    Inventors: Jean-Daniel Bonny, Stefan Hirsch, Oskar Kalb, Peter Pietzonka